MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
17.50
+3.30 (23.24%)
At close: Aug 13, 2025, 4:00 PM
14.75
-2.75 (-15.71%)
Pre-market: Aug 14, 2025, 8:59 AM EDT
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $69.75 million as of August 14, 2025. Its market cap has increased by 99.07% in one year.
Market Cap
69.75M
Enterprise Value
71.63M
1-Year Change
99.07%
Ranking
Category
Stock Price
$17.50
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $69.75M, a decrease of -81.95%. That is a compound annual growth rate of -36.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 69.75M | 152.55% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |